Adicet Bio
ACET

Adicet Bio (ACET) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
WedbushMaintainedOutperform$28.00 from $25.00Sep 29, 2026
HC Wainwright & Co.MaintainedBuy$34.00 from $27.00Sep 28, 2026
HC Wainwright & Co.MaintainedBuy$27.00Sep 18, 2026
GuggenheimMaintainedBuy$90.00 from $100.00Aug 6, 2026
JefferiesInitiated CoverageBuy$19.00 from $8.00May 5, 2026
HC Wainwright & Co.MaintainedBuy$27.00 from $50.00Mar 23, 2026
GuggenheimMaintainedBuy$100.00 from $128.00Mar 13, 2026
HC Wainwright & Co.MaintainedBuy$50.00 from $9.00Jan 21, 2026
Canaccord GenuityMaintainedBuy$18.00 from $128.00Jan 6, 2026
HC Wainwright & Co.MaintainedBuy$9.00 from $4.00Nov 7, 2025
GuggenheimMaintainedBuy$8.00 from $7.00Oct 8, 2025
GuggenheimMaintainedBuy$7.00Sep 19, 2025
HC Wainwright & Co.Initiated CoverageBuy$4.00Jul 23, 2025
GuggenheimMaintainedBuy$7.00Mar 21, 2025
HC Wainwright & Co.MaintainedNeutral—Mar 7, 2025
Citizens Capital MarketsMaintainedMarket Perform—Mar 7, 2025
HC Wainwright & Co.MaintainedNeutral—Feb 27, 2025
JMP SecuritiesMaintainedMarket Perform—Feb 6, 2025
HC Wainwright & Co.MaintainedNeutral—Feb 5, 2025
HC Wainwright & Co.MaintainedNeutral—Dec 19, 2024

Frequently asked questions

  • What is the latest analyst rating on ACET?

    On Sep 29, 2026, Wedbush maintained Adicet Bio at Outperform with a price target of $28.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.